Header Logo

Connection

Meenakshi Jolly to Male

Back to Details
This is a "connection" page, showing publications Meenakshi Jolly has written about Male.
Meenakshi Jolly
Connection Strength
1.397
Male
  1. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
    View in: PubMed
    Score: 0.062
  2. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken). 2019 03; 71(3):406-412.
    View in: PubMed
    Score: 0.052
  3. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019 Feb; 28(2):163-173.
    View in: PubMed
    Score: 0.052
  4. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019 12; 71(12):1647-1652.
    View in: PubMed
    Score: 0.052
  5. Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? Arthritis Care Res (Hoboken). 2018 12; 70(12):1771-1777.
    View in: PubMed
    Score: 0.052
  6. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus. 2018 Apr; 27(5):728-737.
    View in: PubMed
    Score: 0.048
  7. Disease-specific quality of life in patients with lupus nephritis. Lupus. 2018 Feb; 27(2):257-264.
    View in: PubMed
    Score: 0.047
  8. Practice patterns in longitudinal lupus care provision: patient and physician perspectives. Lupus. 2017 Dec; 26(14):1556-1561.
    View in: PubMed
    Score: 0.047
  9. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index. Lupus. 2017 Apr; 26(4):396-402.
    View in: PubMed
    Score: 0.044
  10. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016 06; 68(6):1422-31.
    View in: PubMed
    Score: 0.043
  11. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus. 2016 Jun; 25(7):735-40.
    View in: PubMed
    Score: 0.043
  12. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus. Lupus. 2015 Dec; 24(14):1486-91.
    View in: PubMed
    Score: 0.041
  13. Caregiving, dyadic quality of life and dyadic relationships in lupus. Lupus. 2015 Aug; 24(9):918-26.
    View in: PubMed
    Score: 0.040
  14. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Feb; 67(2):297-304.
    View in: PubMed
    Score: 0.040
  15. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1542-50.
    View in: PubMed
    Score: 0.039
  16. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus. 2014 Dec; 23(14):1452-9.
    View in: PubMed
    Score: 0.038
  17. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus. Lupus. 2014 Aug; 23(9):881-8.
    View in: PubMed
    Score: 0.038
  18. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol. 2014 Aug; 33(8):1079-84.
    View in: PubMed
    Score: 0.036
  19. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol. 2013 Aug; 40(8):1327-33.
    View in: PubMed
    Score: 0.035
  20. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus. 2013 Apr; 22(5):431-6.
    View in: PubMed
    Score: 0.035
  21. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures. J Am Acad Dermatol. 2013 Apr; 68(4):618-623.
    View in: PubMed
    Score: 0.034
  22. Rheumatologists' quality of care for lupus: comparison study between a university and county hospital. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1261-4.
    View in: PubMed
    Score: 0.033
  23. Body image in patients with systemic lupus erythematosus. Int J Behav Med. 2012 Jun; 19(2):157-64.
    View in: PubMed
    Score: 0.033
  24. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65.
    View in: PubMed
    Score: 0.033
  25. A brief assessment tool for body image in systemic lupus erythematosus. Body Image. 2012 Mar; 9(2):279-84.
    View in: PubMed
    Score: 0.032
  26. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):891-8.
    View in: PubMed
    Score: 0.031
  27. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol. 2010 Jun; 37(6):1150-7.
    View in: PubMed
    Score: 0.028
  28. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010 Jan; 69(1):29-33.
    View in: PubMed
    Score: 0.028
  29. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 Jun; 36(6):1209-16.
    View in: PubMed
    Score: 0.027
  30. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005 Sep; 32(9):1706-8.
    View in: PubMed
    Score: 0.021
  31. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6.
    View in: PubMed
    Score: 0.018
  32. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1498-1507.
    View in: PubMed
    Score: 0.017
  33. Fatigue and its correlates in Indian patients with systemic lupus erythematosus. Clin Rheumatol. 2021 Mar; 40(3):905-911.
    View in: PubMed
    Score: 0.015
  34. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients. Lupus. 2020 Nov; 29(13):1727-1735.
    View in: PubMed
    Score: 0.015
  35. Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study. Lupus. 2020 Nov; 29(13):1781-1789.
    View in: PubMed
    Score: 0.015
  36. Patient-Reported Outcomes Predict Mortality in Lupus. Arthritis Care Res (Hoboken). 2019 08; 71(8):1028-1035.
    View in: PubMed
    Score: 0.013
  37. Validation of SIMPLE Index for Lupus Disease Activity. J Clin Rheumatol. 2018 Sep; 24(6):313-318.
    View in: PubMed
    Score: 0.013
  38. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017 06; 69(6):842-848.
    View in: PubMed
    Score: 0.012
  39. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283.
    View in: PubMed
    Score: 0.011
  40. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 2017 Aug; 26(9):967-974.
    View in: PubMed
    Score: 0.011
  41. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus. 2017 Jul; 26(8):849-856.
    View in: PubMed
    Score: 0.011
  42. Validation of the Lupus Impact Tracker in an Australian patient cohort. Lupus. 2017 Jan; 26(1):98-105.
    View in: PubMed
    Score: 0.011
  43. Pain and depression predict self-reported fatigue/energy in lupus. Lupus. 2013 Jun; 22(7):684-9.
    View in: PubMed
    Score: 0.009
  44. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581.
    View in: PubMed
    Score: 0.008
  45. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011 Oct; 20(12):1285-92.
    View in: PubMed
    Score: 0.008
  46. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53.
    View in: PubMed
    Score: 0.008
  47. Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 2011 Jan; 20(1):80-4.
    View in: PubMed
    Score: 0.007
  48. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010 Aug; 12(4):237-49.
    View in: PubMed
    Score: 0.007
  49. Patient reported outcomes and analgesia use in osteoarthritis of the knee. Osteoarthritis Cartilage. 2008 Nov; 16(11):1294-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.